Cargando…

Proinflammatory IgG Fc structures in patients with severe COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections can cause Coronavirus Disease 2019 (COVID-19), which manifests with a range of severities from mild illness to life threatening pneumonia and multi-organ failure. Severe COVID-19 is characterized by an inflammatory signature inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Saborni, Gonzalez, Joseph, Edwards, Karlie, Mallajosyula, Vamsee, Buzzanco, Anthony S., Sherwood, Robert, Buffone, Cindy, Kathale, Nimish, Providenza, Susan, Xie, Markus M., Andrews, Jason R., Blish, Catherine A., Singh, Upinder, Dugan, Haley, Wilson, Patrick C., Pham, Tho D., Boyd, Scott D., Nadeau, Kari C., Pinsky, Benjamin A., Zhang, Sheng, Memoli, Matthew J., Taubenberger, Jeffery K., Morales, Tasha, Schapiro, Jeffrey M., Tan, Gene S., Jagannathan, Prasanna, Wang, Taia T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130642/ https://www.ncbi.nlm.nih.gov/pubmed/33169014 http://dx.doi.org/10.1038/s41590-020-00828-7

Ejemplares similares

SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
por: Chakraborty, Saborni, et al.
Publicado: (2021)

Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19
por: Pickering, Chad, et al.
Publicado: (2022)

CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
por: Mallajosyula, Vamsee, et al.
Publicado: (2021)

Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants
por: Thulin, Natalie K., et al.
Publicado: (2020)

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
por: Chakraborty, Saborni, et al.
Publicado: (2022)

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
por: Sievers, Benjamin L., et al.
Publicado: (2022)

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19
por: Hu, Zicheng, et al.
Publicado: (2022)

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines
por: Sutton, Troy C., et al.
Publicado: (2017)

TNF-α(+) CD4(+) T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
por: van der Ploeg, Kattria, et al.
Publicado: (2022)

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
por: Jagannathan, Prasanna, et al.
Publicado: (2021)

Heterogeneity in IgG‐CD16 signaling in infectious disease outcomes
por: Gonzalez, Joseph C., et al.
Publicado: (2022)

Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study
por: Hu, Zicheng, et al.
Publicado: (2022)

Inflammatory but not respiratory symptoms are associated with ongoing upper airway viral shedding in outpatients with uncomplicated COVID-19
por: Jacobson, Karen B., et al.
Publicado: (2022)

mTOR signaling regulates central and peripheral circadian clock function
por: Ramanathan, Chidambaram, et al.
Publicado: (2018)

Interferon-γ Release Assay for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus 2 T-Cell Response
por: Murugesan, Kanagavel, et al.
Publicado: (2020)

Influenza in pregnancy
por: Memoli, Matthew J., et al.
Publicado: (2012)

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
por: Giurgea, Luca T., et al.
Publicado: (2020)

Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype
por: Mallajosyula, V. Vamsee Aditya, et al.
Publicado: (2015)

Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus
por: Kash, John C., et al.
Publicado: (2010)

Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the ‘Sa’ Antigenic Site
por: Shembekar, Nachiket, et al.
Publicado: (2013)

Proinflammatory (CD14+CD16++) monocytes in type 2 diabetes mellitus patients with/without chronic periodontitis
por: Jagannathan, Raghunathan, et al.
Publicado: (2019)

Illuminating the Fc dependence of SARS-CoV-2 neutralization
por: González, Joseph C., et al.
Publicado: (2021)

The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses
por: Thulin, Natalie K., et al.
Publicado: (2018)

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2020)

SARS-CoV-2 Subgenomic RNA Kinetics in Longitudinal Clinical Samples
por: Verma, Renu, et al.
Publicado: (2021)

A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
por: Kizilay Mancini, Özge, et al.
Publicado: (2017)

mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
por: Röltgen, Katharina, et al.
Publicado: (2021)

Stalking influenza by vaccination with pre-fusion headless HA mini-stem
por: Valkenburg, Sophie A., et al.
Publicado: (2016)

Standardized and optimized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA
por: Natarajan, Aravind, et al.
Publicado: (2021)

Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA
por: Natarajan, Aravind, et al.
Publicado: (2021)

Publisher Correction: Standardized preservation, extraction and quantification techniques for detection of fecal SARS-CoV-2 RNA
por: Natarajan, Aravind, et al.
Publicado: (2021)

The PB2-E627K Mutation Attenuates Viruses Containing the 2009 H1N1 Influenza Pandemic Polymerase
por: Jagger, Brett W., et al.
Publicado: (2010)

SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness
por: Röltgen, Katharina, et al.
Publicado: (2020)

Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I
por: Sutterwala, Fayyaz S., et al.
Publicado: (1998)

Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection
por: Choi, Shannon S., et al.
Publicado: (2023)

Proinflammatory Cytokines in Peritonitis
por: Badiu, DC, et al.
Publicado: (2011)

Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
por: Wirz, Oliver F., et al.
Publicado: (2021)

B cell clonal expansion and convergent antibody responses to SARS-CoV-2
por: Nielsen, Sandra C. A., et al.
Publicado: (2020)

Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2
por: Gao, Ang, et al.
Publicado: (2021)

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
por: Röltgen, Katharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ss1pdk74o1m6hu19301ea9a1ve